Rapid, point of care diagnostic for malaria, highly sensitive for P. Vivax, with species differentiation
Ended Project Grant Awarded Last action
- Award ID
- R44AI155116
- Recipient
-
Hemex Health Inc. UEI LSJ7WFKBJWW4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,323,840
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Funding
-
- $2,496,040.00 Federal
- $827,800.00 Non-federal
- Place of performance
- Portland, OR 97239, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $827,800 | $0 | |
| Amendment | $827,800 | $827,800 | |
| Original award | $840,440 | $0 |
Quick answers
Who received award R44AI155116?
R44AI155116 was awarded to Hemex Health Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 6, 2020.
How much is award R44AI155116 worth?
$3,323,840 has been obligated on R44AI155116: $2,496,040 in federal funding and $827,800 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award